Laboratorios Farmaceuticos Rovi (LABFF) Stock Price, News & Analysis

Company Overview

Laboratorios Farmacéuticos ROVI S.A. is a Spanish specialty pharmaceutical company focused on the development, manufacturing and commercialization of injectable therapies. The company has built expertise in low-molecular-weight heparins and long-acting injectable antipsychotics, alongside drug-delivery technologies such as prefilled syringes and autoinjector systems. ROVI’s product portfolio spans both originator and biosimilar medicines, targeting therapeutic areas including psychiatry, oncology and cardiology.

ROVI’s core franchise includes established anticoagulant products based on tinzaparin sodium, as well as innovative depot formulations of risperidone developed using its proprietary in situ microparticle (ISM) technology. The ISM platform enables once-monthly administration without the need for cold-chain handling, supporting patient adherence in outpatient and institutional settings. In recent years, the company has advanced its R&D pipeline with new injectable candidates in partnership with global pharmaceutical firms.

Headquartered in Madrid, Spain, ROVI maintains multiple manufacturing facilities in Europe and has established a presence in key markets across the European Union, Latin America and Asia. Through licensing agreements and collaborative supply arrangements, the company supplies both branded and unbranded products in over 40 countries. ROVI is also expanding its commercial footprint in North America via partnerships with specialty pharmaceutical distributors.

Founded in 1946, ROVI has grown from a domestic heparin producer into a global specialty pharma company with a focus on differentiated injections and biosimilars. With ongoing investments in its production network and technology platforms, ROVI aims to support sustainable growth by addressing unmet needs in chronic and hospital-based therapies.

Key Stats

• Today's Range: C$65.86 to C$65.86
• 50-Day Range: C$65.86 to C$65.86
• 52-Week Range: C$65.86 to C$65.86
• Volume: N/A
• Average Volume: 1,300 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

LABFF Stock Analysis - Frequently Asked Questions

How have LABFF shares performed this year?

Laboratorios Farmaceuticos Rovi's stock was trading at C$65.86 at the beginning of 2025. Since then, LABFF stock has increased by 0.0% and is now trading at C$65.86.

How do I buy shares of Laboratorios Farmaceuticos Rovi?

Shares of LABFF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:LABFF
• CIK: N/A
• Web: www.rovi.es
• Phone: 34 91 021 30 00
• Fax: N/A
• Employees: 1,925
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A